Other studies have found that patients with RIS and serum NFL levels higher than 5 ​pg/mL are more likely to convert to MS, further substantiating that biomarkers may be useful even in patient without clinical symptoms but an MRI that is compatible with MS. This evidence concerns the gene NEFL and myeloid sarcoma.